Vertex Pharmaceuticals
VRTX
#173
Rank
A$174.50 B
Marketcap
A$680.61
Share price
4.17%
Change (1 day)
-12.42%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): A$6.93 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$11.72 Billion. In 2024 the company made an earning of A$0.39 Billion a decrease over its 2023 earnings that were of A$6.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$6.93 B1644.14%
2024 A$0.39 B-93.69%
2023 A$6.30 B3.19%
2022 A$6.10 B53.56%
2021 A$3.97 B-12.06%
2020 A$4.52 B118.45%
2019 A$2.06 B120.64%
2018 A$0.93 B1473.64%
2017 A$59.61 M197.6%
2016 A$20.03 M-102.97%
2015 -A$0.68 Billion-28.46%
2014 -A$0.95 Billion-51.5%
2013 -A$1.95 Billion-30584.68%
2012 A$6.37 M-95.47%
2011 A$0.14 B
2009 -A$0.85 Billion
2007 -A$0.59 Billion83.1%
2006 -A$0.33 Billion59.02%
2005 -A$0.21 Billion3.28%
2004 -A$0.2 Billion-38.16%
2003 -A$0.32 Billion
2000 -A$54.18 Million-20.38%
1999 -A$68.05 Million31.62%
1998 -A$51.7 Million91.05%
1997 -A$27.06 Million-36.24%
1996 -A$42.44 Million12.45%
1995 -A$37.74 Million27.4%
1994 -A$29.63 Million-1833.33%
1993 A$1.7 M-112.12%
1992 -A$14.1 Million175%
1991 -A$5.13 Million-12.2%
1990 -A$5.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.13 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.36 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.07 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.88 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.43 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$0.11 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA